Skip to main content


National Guidelines

  1. Guidance for prevention and management of COVID-19 in children and adolescents: A consensus statement from the Pediatric Infectious Diseases Society Pediatric COVID-19 Therapies Taskforce. J Pediatr Infect Dis Soc. 2024;13(3):159–185
  2. The II Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19. Crit Care Sci 2023;35(3):243-255
  3. Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine. Rev Bras Ter Intensiva 2021;33(4):487-536
  4. The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: Therapy section. J Infect Public Health 2021;epublished October 20th
  5. Bassetti. Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infect Dis Ther 2021;10:1837–1885
  6. Malin. Key summary of German national treatment guidance for hospitalized COVID-19 patients Key pharmacologic recommendations from a national German living guideline using an Evidence to Decision Framework (last updated 17.05.2021). Infection 2021;epublished July 6th
  7. Intensive Care Society. Clinical guide for the management of critical care for adults with COVID-19 during the Coronavirus pandemic. ICS 2020;epublished October 28th
  8. Köstenberger. SARS-CoV-2: recommendations for treatment in intensive care medicine. Wien Klin Wochenschr 2020;epublished September 18th